Decibel Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Decibel Therapeutics

09/11/2022 22:56

* Decibel Therapeutics Inc  DBTX.OQ  reported a quarterly
adjusted
loss of 64 cents​​ per share for the quarter ended in September.
The mean expectation of six analysts for the quarter was for a
loss of 69 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Decibel Therapeutics Inc's reported EPS for the quarter
was a
loss of 64 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Decibel Therapeutics Inc shares had fallen by 5.2% this
quarter and lost 29.5% so far this year.
    * The company reported a quarterly loss of $16.01 million.
    * Wall Street's median 12-month price target for Decibel
Therapeutics Inc is $12.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:56 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.69          -0.64          Beat
 Jun. 30 2022      -0.57          -0.68          Missed
 Mar. 31 2022      -0.56          -0.56          Met
 Dec. 31 2021      -0.47          -0.49          Missed